Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Hidradenitis suppurativa may be a type of autoinflammatory skin disease linked to gene mutations and immune system issues.

Cataract surgery in Europe varies in frequency and cost between countries.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

The journal covered various dermatology topics, including treatments, disease management, and research findings.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Endoglin is crucial for proper hair growth cycles and stem cell activation in mice.

Some vaccines might rarely cause hair loss, more research is needed.

Topical drugs and near-infrared light therapy show potential for treating alopecia.